Research programme: G protein-coupled receptor modulators - Eli Lilly and Company/Suven Life Sciences
Latest Information Update: 04 Nov 2017
At a glance
- Originator Eli Lilly and Company; Suven Life Sciences
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in CNS-disorders in India (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in CNS-disorders in USA (PO)
- 07 Sep 2009 A lead compound has been identified from this programme